Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial barrier is a critical physiological system composed of a single layer of epithelial cells and their associated junctional complexes, including tight junctions, adherens junctions, and desmosomes (PMID: 23307037). Its primary function is to maintain a selective barrier that allows for the absorption of nutrients and water while preventing the translocation of luminal pathogens, toxins, and antigens into the systemic circulation (PMID: 28123248). Key proteins involved in this structure include claudins, occludin, and zonula occludens-1 (ZO-1), which regulate paracellular permeability. Impairment of these proteins leads to increased intestinal permeability, a condition associated with inflammatory bowel disease, celiac disease, and various metabolic disorders (PMID: 33072622). Therapeutic interventions aim to stabilize these protein-protein interactions or inhibit regulatory pathways, such as the zonulin pathway, to restore barrier integrity and reduce systemic inflammation (PMID: 25567115).
Pharmacological agents target the intestinal barrier by inhibiting zonulin-mediated tight junction disassembly, activating chloride channels to promote mucosal repair, or reducing pro-inflammatory cytokines that degrade junctional proteins (PMID: 25567115, 28123248).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial barrier proteins.